Impact of patient phenotype on the relationship between accelerometer-derived physical activity and cardiovascular events in atrial fibrillation

Boidin, M orcid iconORCID: 0000-0002-1522-1223, Buckley, B orcid iconORCID: 0000-0002-1479-8872, Lip, GYH orcid iconORCID: 0000-0002-7566-1626 and Thijssen, DHJ orcid iconORCID: 0000-0002-7707-5567 (2025) Impact of patient phenotype on the relationship between accelerometer-derived physical activity and cardiovascular events in atrial fibrillation. American Journal of Preventive Cardiology, 25. ISSN 2666-6677

[thumbnail of Impact of patient phenotype on the relationship between accelerometer-derived physical activity and cardiovascular events in atrial fibrillation.pdf]
Preview
Text
Impact of patient phenotype on the relationship between accelerometer-derived physical activity and cardiovascular events in atrial fibrillation.pdf - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview
Open Access URL: https://www.sciencedirect.com/science/article/pii/... (Published version)

Abstract

Aims
Atrial fibrillation (AF) is a heterogeneous condition with varying comorbidity profiles, yet current physical activity guidelines do not differentiate between AF phenotypes. We examined the association between objectively measured moderate-to-vigorous physical activity (MVPA) and major adverse cardiovascular events (MACE) across different AF phenotypes.
Methods
In a prospective cohort of 4858 adults with AF (mean age 63, 37 % female) from the UK Biobank, wrist-worn accelerometry quantified MVPA. Hierarchical clustering classified individuals into 'high' and 'low' risk clusters based on comorbidities. Activity patterns were also described by rhythm control treatment status. Cox-proportional hazards models assessed the association between MVPA and MACE across clusters, while Poisson regression identified notable MVPA thresholds.
Results
The 'high-risk' cluster (n = 2583) experienced more MACE (HR: 3.81, 95 %CI: 3.19–4.55, p < 0.001) than the 'low-risk' cluster (n = 2275). Greater MVPA was associated with lower MACE incidence in both clusters. In the 'low risk' cluster, those with median MVPA of 187 min/week had lower MACE incidence (HR 0.39, 95 %CI 0.22–0.70, p = 0.001) than the reference group (median 56 min/week). In the 'high risk' cluster, those with median MVPA of 167 min/week had lower MACE incidence (HR 0.57, 95 %CI 0.44–0.74, p < 0.001) than their reference group (median 42 min/week). Poisson models identified 35 and 103 min/week as notable thresholds (IRRs: 0.35 and 0.31, respectively; both p < 0.001). Among patients undergoing rhythm control (n = 1354), higher MVPA was associated with lower MACE incidence (HR 0.42, 95 %CI 0.26–0.66, p < 0.001).
Conclusion
In this AF cohort, higher MVPA was associated with lower MACE incidence across different risk phenotypes and treatment statuses.

Item Type: Article
Uncontrolled Keywords: 3201 Cardiovascular medicine and haematology
Subjects: R Medicine > RC Internal medicine > RC1200 Sports Medicine
Divisions: Sport and Exercise Sciences
Publisher: Elsevier
Date of acceptance: 29 November 2025
Date of first compliant Open Access: 9 December 2025
Date Deposited: 09 Dec 2025 13:07
Last Modified: 09 Dec 2025 13:07
DOI or ID number: 10.1016/j.ajpc.2025.101362
URI: https://researchonline.ljmu.ac.uk/id/eprint/27692
View Item View Item